After several decades of in-vitro fertilisation and intra cytoplasmic sperm injection (ICSI), the pregnancy and birth rate has often been mentioned. While these rates have apparently not been well determined in the United States or England (Reproductive Biomedicine. Online 27; 1-3, 2013), figures are available for Australia and New Zealand for the period 2009-2011. The pregnancy rate for women commencing this treatment is 54% and for live births is 40%, after five cycles. These rates do not improve when the number of cycles exceeds five (Reproductive Biomedicine. Online 28; 405, 2014).